Victoria Morris
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Victoria Morris has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Carolyn G. Rasmussen
Department of Botany and Plant Sciences, Center for Plant Cell Biology, University of California, Riverside, USA
3 shared publications - Alison M. Mills
Graduate Group in Biochemistry and Molecular Biology
2 shared publications - Chenery Lowe
Center for Biomedical Ethics, Department of Pediatrics Stanford University Stanford California USA
2 shared publications - Debra J. H. Mathews
Johns Hopkins University, Baltimore, Maryland, USA
2 shared publications - Laura Duncan
Research and Translational Genetic Counseling Unit, Clinical Research Mayo Clinic Jacksonville Florida USA
2 shared publications - Laynie Dratch
Penn Frontotemporal Degeneration Center, Department of Neurology, School of Medicine, University of Pennsylvania, Philadelphia, PA, United States
2 shared publications
Latest Publications
- 12 May 2025
- Published by Wiley in Journal of Genetic Counseling
- Vol. 34 (3) , e70005
Navigating the impact of the 21st‐Century Cures Act Final Rule: A national cross‐sectional survey of US genetic counselors
The 21st Century Cures Act Final Rule (Final Rule) increases patient access to their health records but raises concerns about distress and misunderstanding of automatically released results and documentation. Little is known about genetic counselors' (GCs') experiences with the Final Rule. In Fall 2023, we conducted a cross‐sectional survey of US GCs about the Final Rule's perceived impact on practice and assessed if being the ordering versus non‐ordering provider for genetic testing affected perceptions of Final Rule‐related changes. GCs (n = 102) reported demographic and workplace characteristics, institutional policy changes, workflow changes, and perceived patient harms and benefits due to the Final Rule. To compare ordering and non‐ordering providers, we conducted Fisher's exact tests for categorical variables and trend tests for ordinal variables. Open‐response questions elicited examples of positive and negative patient impacts, the effects of patient characteristics, and practice changes in response to the Final Rule. Twenty‐seven GCs were ordering providers and 66 were non‐ordering providers. Relative to ordering providers, non‐ordering providers expressed stronger agreement with statements indicating concern about the emotional impact on patients reviewing results or notes without support (p = 0.002, 33% vs. 51% strongly agree), patients misunderstanding or misinterpreting results (p = 0.025, 44% vs. 70% strongly agree), and patients contacting the inappropriate party to discuss results (p = 0.023, 19% vs. 48% strongly agree). Agreement with the statement “patients have more knowledge/context/questions at our disclosure session due to previous results review” also differed by ordering provider status (p = 0.007). In open responses, GCs expressed concerns about patients' strong emotional reactions, patients misinterpreting results, workflow disruptions, and widening health disparities. Benefits included patients' ability to be reassured, informed, or empowered earlier; ease of sharing health information; more efficient workflow due to the automatic release of results. These results emphasize the importance of clear communication within health systems and between patients and providers.
- 12 May 2025
- Published by Wiley in Journal of Genetic Counseling
- Vol. 34 (3) , e70005
Navigating the impact of the 21st‐Century Cures Act Final Rule: A national cross‐sectional survey of US genetic counselors
The 21st Century Cures Act Final Rule (Final Rule) increases patient access to their health records but raises concerns about distress and misunderstanding of automatically released results and documentation. Little is known about genetic counselors' (GCs') experiences with the Final Rule. In Fall 2023, we conducted a cross‐sectional survey of US GCs about the Final Rule's perceived impact on practice and assessed if being the ordering versus non‐ordering provider for genetic testing affected perceptions of Final Rule‐related changes. GCs (n = 102) reported demographic and workplace characteristics, institutional policy changes, workflow changes, and perceived patient harms and benefits due to the Final Rule. To compare ordering and non‐ordering providers, we conducted Fisher's exact tests for categorical variables and trend tests for ordinal variables. Open‐response questions elicited examples of positive and negative patient impacts, the effects of patient characteristics, and practice changes in response to the Final Rule. Twenty‐seven GCs were ordering providers and 66 were non‐ordering providers. Relative to ordering providers, non‐ordering providers expressed stronger agreement with statements indicating concern about the emotional impact on patients reviewing results or notes without support (p = 0.002, 33% vs. 51% strongly agree), patients misunderstanding or misinterpreting results (p = 0.025, 44% vs. 70% strongly agree), and patients contacting the inappropriate party to discuss results (p = 0.023, 19% vs. 48% strongly agree). Agreement with the statement “patients have more knowledge/context/questions at our disclosure session due to previous results review” also differed by ordering provider status (p = 0.007). In open responses, GCs expressed concerns about patients' strong emotional reactions, patients misinterpreting results, workflow disruptions, and widening health disparities. Benefits included patients' ability to be reassured, informed, or empowered earlier; ease of sharing health information; more efficient workflow due to the automatic release of results. These results emphasize the importance of clear communication within health systems and between patients and providers.
- Open Access
Navigating the Impact of the 21st Century Cures Act Final Rule: A National Cross-Sectional Survey of U.S. Genetic Counselors
The 21 st Century Cures Act Final Rule (Final Rule) increases patient access to their health records but raises concerns about distress and misunderstanding of automatically released results and documentation. Little is known about genetic counselors’ (GCs’) experiences with the Final Rule. In Fall 2023, we conducted a cross-sectional survey of U.S. GCs about the Final Rule’s perceived impact on practice and assessed if being the ordering versus non-ordering provider for genetic testing affected perceptions of Final Rule-related changes. GCs (n=102) reported demographic and workplace characteristics, institutional policy changes, workflow changes, and perceived patient harms and benefits due to the Final Rule. To compare ordering and non-ordering providers, we conducted Fisher’s exact tests for categorical variables and trend tests for ordinal variables. Open response questions elicited examples of positive and negative patient impacts, the effects of patient characteristics, and practice changes in response to the Final Rule. Twenty-seven GCs were ordering providers and 66 were non-ordering providers. Relative to ordering providers, non-ordering providers expressed stronger agreement with statements indicating concern about the emotional impact on patients reviewing results or notes without support (P=0.002, 33% vs. 51% strongly agree), patients misunderstanding or misinterpreting results (P=0.025, 44% vs. 70% strongly agree), and patients contacting the inappropriate party to discuss results (P=0.023, 19% vs. 48% strongly agree). Agreement with the statement “patients have more knowledge/context/questions at our disclosure session due to previous results review” also differed by ordering provider status (P=0.007). In open responses, GCs expressed concerns about patients’ strong emotional reactions, patients misinterpreting results, workflow disruptions, and widening health disparities. Benefits included patients’ ability to be reassured, informed, or empowered earlier; ease of sharing health information; and more efficient workflow due to automatic release of results. These results emphasize the importance of clear communication within health systems and between patients and providers. What is known about this topic: The 21 Century Cures Act Final Rule (Final Rule) increases patients’ access to their health records, including automatically released results and clinical documentation. In prior studies, physicians and physician-led care team members recognize potential benefits for patient empowerment and potential harms due to information overload and misunderstanding, but little is known about mid-level providers’ perspectives, including genetic counselors. What this paper adds to the topic: In a national survey, U.S. genetic counselors expressed worries about direct release of genetic test results, including concerns about patients’ emotional responses, risks related to misinterpretation of results and next steps, and the impact on their workflow. The study offers suggestions on how GCs can navigate changes imposed by the Final Rule.
Open AccessNavigating the Impact of the 21st Century Cures Act Final Rule: A National Cross-Sectional Survey of U.S. Genetic Counselors
The 21 st Century Cures Act Final Rule (Final Rule) increases patient access to their health records but raises concerns about distress and misunderstanding of automatically released results and documentation. Little is known about genetic counselors’ (GCs’) experiences with the Final Rule. In Fall 2023, we conducted a cross-sectional survey of U.S. GCs about the Final Rule’s perceived impact on practice and assessed if being the ordering versus non-ordering provider for genetic testing affected perceptions of Final Rule-related changes. GCs (n=102) reported demographic and workplace characteristics, institutional policy changes, workflow changes, and perceived patient harms and benefits due to the Final Rule. To compare ordering and non-ordering providers, we conducted Fisher’s exact tests for categorical variables and trend tests for ordinal variables. Open response questions elicited examples of positive and negative patient impacts, the effects of patient characteristics, and practice changes in response to the Final Rule. Twenty-seven GCs were ordering providers and 66 were non-ordering providers. Relative to ordering providers, non-ordering providers expressed stronger agreement with statements indicating concern about the emotional impact on patients reviewing results or notes without support (P=0.002, 33% vs. 51% strongly agree), patients misunderstanding or misinterpreting results (P=0.025, 44% vs. 70% strongly agree), and patients contacting the inappropriate party to discuss results (P=0.023, 19% vs. 48% strongly agree). Agreement with the statement “patients have more knowledge/context/questions at our disclosure session due to previous results review” also differed by ordering provider status (P=0.007). In open responses, GCs expressed concerns about patients’ strong emotional reactions, patients misinterpreting results, workflow disruptions, and widening health disparities. Benefits included patients’ ability to be reassured, informed, or empowered earlier; ease of sharing health information; and more efficient workflow due to automatic release of results. These results emphasize the importance of clear communication within health systems and between patients and providers. What is known about this topic: The 21 Century Cures Act Final Rule (Final Rule) increases patients’ access to their health records, including automatically released results and clinical documentation. In prior studies, physicians and physician-led care team members recognize potential benefits for patient empowerment and potential harms due to information overload and misunderstanding, but little is known about mid-level providers’ perspectives, including genetic counselors. What this paper adds to the topic: In a national survey, U.S. genetic counselors expressed worries about direct release of genetic test results, including concerns about patients’ emotional responses, risks related to misinterpretation of results and next steps, and the impact on their workflow. The study offers suggestions on how GCs can navigate changes imposed by the Final Rule.
- Open Access
- 25 August 2022
- Published by Oxford University Press (OUP) in The Plant Cell
- Vol. 34 (11) , 4583-4599
The localization of PHRAGMOPLAST ORIENTING KINESIN1 at the division site depends on the microtubule-binding proteins TANGLED1 and AUXIN-INDUCED IN ROOT CULTURES9 in Arabidopsis
Proper plant growth and development require spatial coordination of cell divisions. Two unrelated microtubule-binding proteins, TANGLED1 (TAN1) and AUXIN-INDUCED IN ROOT CULTURES9 (AIR9), are together required for normal growth and division plane orientation in Arabidopsis (Arabidopsis thaliana). The tan1 air9 double mutant has synthetic growth and division plane orientation defects, while single mutants lack obvious defects. Here we show that the division site-localized protein, PHRAGMOPLAST ORIENTING KINESIN1 (POK1), was aberrantly lost from the division site during metaphase and telophase in the tan1 air9 mutant. Since TAN1 and POK1 interact via the first 132 amino acids of TAN1 (TAN11–132), we assessed the localization and function of TAN11–132 in the tan1 air9 double mutant. TAN11–132 rescued tan1 air9 mutant phenotypes and localized to the division site during telophase. However, replacing six amino-acid residues within TAN11–132, which disrupted the POK1–TAN1 interaction in the yeast-two-hybrid system, caused loss of both rescue and division site localization of TAN11–132 in the tan1 air9 mutant. Full-length TAN1 with the same alanine substitutions had defects in phragmoplast guidance and reduced TAN1 and POK1 localization at the division site but rescued most tan1 air9 mutant phenotypes. Together, these data suggest that TAN1 and AIR9 are required for POK1 localization, and yet unknown proteins may stabilize TAN1–POK1 interactions.
- 25 August 2022
- Published by Oxford University Press (OUP) in The Plant Cell
- Vol. 34 (11) , 4583-4599
Open AccessThe localization of PHRAGMOPLAST ORIENTING KINESIN1 at the division site depends on the microtubule-binding proteins TANGLED1 and AUXIN-INDUCED IN ROOT CULTURES9 in Arabidopsis
Proper plant growth and development require spatial coordination of cell divisions. Two unrelated microtubule-binding proteins, TANGLED1 (TAN1) and AUXIN-INDUCED IN ROOT CULTURES9 (AIR9), are together required for normal growth and division plane orientation in Arabidopsis (Arabidopsis thaliana). The tan1 air9 double mutant has synthetic growth and division plane orientation defects, while single mutants lack obvious defects. Here we show that the division site-localized protein, PHRAGMOPLAST ORIENTING KINESIN1 (POK1), was aberrantly lost from the division site during metaphase and telophase in the tan1 air9 mutant. Since TAN1 and POK1 interact via the first 132 amino acids of TAN1 (TAN11–132), we assessed the localization and function of TAN11–132 in the tan1 air9 double mutant. TAN11–132 rescued tan1 air9 mutant phenotypes and localized to the division site during telophase. However, replacing six amino-acid residues within TAN11–132, which disrupted the POK1–TAN1 interaction in the yeast-two-hybrid system, caused loss of both rescue and division site localization of TAN11–132 in the tan1 air9 mutant. Full-length TAN1 with the same alanine substitutions had defects in phragmoplast guidance and reduced TAN1 and POK1 localization at the division site but rescued most tan1 air9 mutant phenotypes. Together, these data suggest that TAN1 and AIR9 are required for POK1 localization, and yet unknown proteins may stabilize TAN1–POK1 interactions.
- Open Access
The localization of PHRAGMOPLAST ORIENTING KINESIN1 at the division site depends on two microtubule binding proteins TANGLED1 and AUXIN-INDUCED-IN-ROOT-CULTURES9 in Arabidopsis
Proper plant growth and development requires spatial coordination of cell divisions. Two unrelated microtubule-binding proteins, TANGLED1 (TAN1) and AUXIN-INDUCED-IN-ROOT-CULTURES9 (AIR9), are together required for normal growth and division-plane orientation in Arabidopsis. tan1 air9 double mutants have synthetic growth and division-plane orientation defects while single mutants lack obvious defects. Here we show that the division-site localized protein, PHRAGMOPLAST-ORIENTING-KINESIN1 (POK1), was aberrantly lost from the division site during metaphase and telophase in tan1 air9 mutants. Since TAN1 and POK1 interact via the first 132 amino acids of TAN1 (TAN1 1-132 ), we assessed its localization and function in the tan1 air9 double mutant. TAN1 1-132 rescued tan1 air9 mutant phenotypes and localized to the division site in telophase. However, replacing six amino-acid residues within TAN1 1-132 that disrupts POK1-TAN1 interaction in the yeast-two-hybrid system caused loss of both rescue and division-site localization of TAN1 1-132 in tan1 air9 mutants. Full-length TAN1 with the same alanine substitutions had defects in phragmoplast guidance and reduced TAN1 and POK1 localization at the division site but rescued most tan1 air9 mutant phenotypes. Together, these data suggest that TAN1 and AIR9 are required for POK1 localization, and yet unknown proteins may stabilize TAN1-POK1 interactions. One sentence summary: Specific amino acids within TAN1 are required for its correct localization and function partially through interaction with POK1; both TAN1 and AIR9 mediate POK1 division site localization.
Open AccessThe localization of PHRAGMOPLAST ORIENTING KINESIN1 at the division site depends on two microtubule binding proteins TANGLED1 and AUXIN-INDUCED-IN-ROOT-CULTURES9 in Arabidopsis
Proper plant growth and development requires spatial coordination of cell divisions. Two unrelated microtubule-binding proteins, TANGLED1 (TAN1) and AUXIN-INDUCED-IN-ROOT-CULTURES9 (AIR9), are together required for normal growth and division-plane orientation in Arabidopsis. tan1 air9 double mutants have synthetic growth and division-plane orientation defects while single mutants lack obvious defects. Here we show that the division-site localized protein, PHRAGMOPLAST-ORIENTING-KINESIN1 (POK1), was aberrantly lost from the division site during metaphase and telophase in tan1 air9 mutants. Since TAN1 and POK1 interact via the first 132 amino acids of TAN1 (TAN1 1-132 ), we assessed its localization and function in the tan1 air9 double mutant. TAN1 1-132 rescued tan1 air9 mutant phenotypes and localized to the division site in telophase. However, replacing six amino-acid residues within TAN1 1-132 that disrupts POK1-TAN1 interaction in the yeast-two-hybrid system caused loss of both rescue and division-site localization of TAN1 1-132 in tan1 air9 mutants. Full-length TAN1 with the same alanine substitutions had defects in phragmoplast guidance and reduced TAN1 and POK1 localization at the division site but rescued most tan1 air9 mutant phenotypes. Together, these data suggest that TAN1 and AIR9 are required for POK1 localization, and yet unknown proteins may stabilize TAN1-POK1 interactions. One sentence summary: Specific amino acids within TAN1 are required for its correct localization and function partially through interaction with POK1; both TAN1 and AIR9 mediate POK1 division site localization.
- 1 May 2020
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2020-01 (6) , 637
Monitoring Plant Health with Near Infrared Fluorescent H2O2 Nanosensors
Nanotechnology-based sensors are promising tools for optimizing plant performance and use of resources in agriculture by equipping plants with capabilities to report when they are under stress and require intervention. Herein, we interfaced near infrared (nIR) fluorescent nanosensors with plant leaves that report hydrogen peroxide (H2O2), a key signaling molecule associated with the onset of plant environmental and pathogen stresses. For this purpose, we used single-walled carbon nanotubes (SWCNT) as non-photobleaching fluorescent building blocks for H2O2 nanoscale sensors with a nIR fluorescent emission (> 800 nm) in a ultra-low background region that is ideal for high-sensitivity remote sensing and imaging. SWCNTs were functionalized with a DNA aptamer that binds to hemin, resulting in nIR fluorescence nanosensor response that is quenched by H2O2 in a dose dependent way within the plant physiological range (10-100 H2O2 µM). The in vivo sensor sensitivity for H2O2 (10 µM) allows it to reversibly report signs of stress in plants exposed to UV-B, high light, and a microbial pathogen related peptide (flg 22), but not mechanical leaf wounding. The sensor response was imaged in leaves by a standoff nIR camera, which reported remotely changes in sensor nIR emission up on stress. Such nanotechnology-based sensors report plant signaling molecules associated with early signs of stress and will impact our understanding of plant stress communication, provide novel tools for precision agriculture, and reduce undesirable losses of agrochemicals in the environment.
- 1 May 2020
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2020-01 (6) , 637
Monitoring Plant Health with Near Infrared Fluorescent H2O2 Nanosensors
Nanotechnology-based sensors are promising tools for optimizing plant performance and use of resources in agriculture by equipping plants with capabilities to report when they are under stress and require intervention. Herein, we interfaced near infrared (nIR) fluorescent nanosensors with plant leaves that report hydrogen peroxide (H2O2), a key signaling molecule associated with the onset of plant environmental and pathogen stresses. For this purpose, we used single-walled carbon nanotubes (SWCNT) as non-photobleaching fluorescent building blocks for H2O2 nanoscale sensors with a nIR fluorescent emission (> 800 nm) in a ultra-low background region that is ideal for high-sensitivity remote sensing and imaging. SWCNTs were functionalized with a DNA aptamer that binds to hemin, resulting in nIR fluorescence nanosensor response that is quenched by H2O2 in a dose dependent way within the plant physiological range (10-100 H2O2 µM). The in vivo sensor sensitivity for H2O2 (10 µM) allows it to reversibly report signs of stress in plants exposed to UV-B, high light, and a microbial pathogen related peptide (flg 22), but not mechanical leaf wounding. The sensor response was imaged in leaves by a standoff nIR camera, which reported remotely changes in sensor nIR emission up on stress. Such nanotechnology-based sensors report plant signaling molecules associated with early signs of stress and will impact our understanding of plant stress communication, provide novel tools for precision agriculture, and reduce undesirable losses of agrochemicals in the environment.
- Open Access
- 16 November 2017
- Published by Oxford University Press (OUP) in Plant Physiology
- Vol. 176 (1) , 418-431
Division Plane Orientation Defects Revealed by a Synthetic Double Mutant Phenotype
TANGLED1 (TAN1) and AUXIN-INDUCED-IN-ROOTS9 (AIR9) are microtubule-binding proteins that localize to the division site in plants. Their function in Arabidopsis (Arabidopsis thaliana) remained unclear because neither tan1 nor air9 single mutants have a strong phenotype. We show that tan1 air9 double mutants have a synthetic phenotype consisting of short, twisted roots with disordered cortical microtubule arrays that are hypersensitive to a microtubule-depolymerizing drug. The tan1 air9 double mutants have significant defects in division plane orientation due to failures in placing the new cell wall at the correct division site. Full-length TAN1 fused to yellow fluorescent protein, TAN1-YFP, and several deletion constructs were transformed into the double mutant to assess which regions of TAN1 are required for its function in root growth, root twisting, and division plane orientation. TAN1-YFP expressed in tan1 air9 significantly rescued the double mutant phenotype in all three respects. Interestingly, TAN1 missing the first 126 amino acids, TAN1-ΔI-YFP, failed to rescue the double mutant phenotype, while TAN1 missing a conserved middle region, TAN1-ΔII-YFP, significantly rescued the mutant phenotype in terms of root growth and division plane orientation but not root twisting. We use the tan1 air9 double mutant to discover new functions for TAN1 and AIR9 during phragmoplast guidance and root morphogenesis.
- 16 November 2017
- Published by Oxford University Press (OUP) in Plant Physiology
- Vol. 176 (1) , 418-431
Open AccessDivision Plane Orientation Defects Revealed by a Synthetic Double Mutant Phenotype
TANGLED1 (TAN1) and AUXIN-INDUCED-IN-ROOTS9 (AIR9) are microtubule-binding proteins that localize to the division site in plants. Their function in Arabidopsis (Arabidopsis thaliana) remained unclear because neither tan1 nor air9 single mutants have a strong phenotype. We show that tan1 air9 double mutants have a synthetic phenotype consisting of short, twisted roots with disordered cortical microtubule arrays that are hypersensitive to a microtubule-depolymerizing drug. The tan1 air9 double mutants have significant defects in division plane orientation due to failures in placing the new cell wall at the correct division site. Full-length TAN1 fused to yellow fluorescent protein, TAN1-YFP, and several deletion constructs were transformed into the double mutant to assess which regions of TAN1 are required for its function in root growth, root twisting, and division plane orientation. TAN1-YFP expressed in tan1 air9 significantly rescued the double mutant phenotype in all three respects. Interestingly, TAN1 missing the first 126 amino acids, TAN1-ΔI-YFP, failed to rescue the double mutant phenotype, while TAN1 missing a conserved middle region, TAN1-ΔII-YFP, significantly rescued the mutant phenotype in terms of root growth and division plane orientation but not root twisting. We use the tan1 air9 double mutant to discover new functions for TAN1 and AIR9 during phragmoplast guidance and root morphogenesis.